Empamore Tablets 25mg
| SKU | 2728 |
|---|---|
| Generic For | Empagliflozin |
| Manufacturer | Morepen Labs Ltd. |
| Active Ingredient | Empagliflozin | Expiry | January 2027 |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.83 | US$ 25.00 | |||
|
|||||
| 60 Tablet/s | US$ 0.75 | US$ 45.0010%US$ 50.00 | |||
|
|||||
| 100 Tablet/s | US$ 0.68 | US$ 68.0018%US$ 83.00 | |||
|
|||||
Empamore Tablets 25mg (Empagliflozin)
Empamore 25 mg helps lower blood sugar when used with diet and exercise in adults with type 2 diabetes. The active ingredient in the medicine is Empagliflozin, which works by restricting the activity of certain proteins in the body. By controlling blood sugar levels, the medication also helps protect your kidneys from losing their function. It works in the kidneys to prevent glucose absorption from the blood. Empagliflozin does not work for patients with insulin-dependent or type 1 diabetes. Patients who have type 1 diabetes are advised to use insulin injections.
Empamore also reduces the risk of cardiovascular death and immediate emergency visits for heart failure in adults suffering from heart failure when the heart can’t pump adequate blood to the rest of your body. It is used for the reduction of risk of heart-related death in adults who have type 2 diabetes mellitus and who are also suffering from cardiovascular disorder.
Diabetes medicine is also effective in lowering the risk of worsening renal disease, end-stage renal disorders, cardiovascular death, and emergency hospital visits for heart failure in patients with chronic renal disorders.
Precaution with Empagliflozin 25 mg
- Empamore 25 mg is not meant to be used in people with type 1 diabetes.
- Also, diabetes medication should not be used to achieve glycaemic control in adults with type 2 diabetes who have severe renal insufficiency.
- Empamore can cause a build-up of ketones in your bloodstream, making your blood acidic. This is known as ketoacidosis. The risk may be even higher if a patient is dehydrated or has diarrhea.
- It is not known if Empagliflozin is safe to administer in children. Therefore, it is always recommended to consult a healthcare specialist before giving this medicine to a child.
- The use of other medications with Empamore 25 mg can cause drug interaction. Therefore, a patient should inform their healthcare provider of:
- Medicines that increase urine production. In this case, a healthcare professional may ask a patient to discontinue treatment.
- Medicines such as insulin or sulphonylurea medicine cause a drop in blood sugar. In such cases, the doctor may lower the dose of these other medicines to prevent a hike in blood sugar levels.
- Taking lithium because Empamore 25 mg can cause a significant reduction in the amount of lithium in your bloodstream.
Consumption of Empamore 25 with other diabetes medicines like sulphonylureas or with insulin can cause a significant reduction in blood sugar level, which may cause symptoms like sweating, shaking, and vision changes and may interfere with a patient’s ability to drive a vehicle or use machines complex machinery.
Side Effects of Empagliflozin 25mg
Seek immediate medical attention if you develop:
- Severe allergic reactions - Symptoms of a serious allergic reaction include swelling of the face, mouth, lips, tongue, or throat that may contribute to difficulty breathing and swallowing.
- Hypoglycemia (low blood sugar) - If Empamore is taken with other medicines such as insulin or sulfonylurea, there will be an increased risk of low blood sugar. The signs of low blood sugar include excessive hunger, headache, sweating, shaking, fast heart rate, and feeling anxious or confused.
- Dehydration - The signs of dehydration may include usual tiredness, fainting, loss of consciousness, lightheadedness, or dizziness of standing.
Commonly reported side effects of Empagliflozin are urinary tract infections, yeast infections in females, and needing to pass more urine. Most of these common side effects of the medicine are mild and resolve within a few days of using the medication.
How to use Empagliflozin tablet 25mg?
The usual suggested dose is 10 mg once daily, taken in the morning, before or after eating. Those tolerating the 10 mg dose can be given a 25 mg dose if needed and recommended by the doctor. In cases of kidney insufficiency, doctors usually limit the dose to 10 mg once daily. Doctors usually recommend a suitable strength that is best suited to you. The tablet should be swallowed with a glass full of water. It can be taken before or after consuming food. Those who have type 2 diabetes are often prescribed another diabetes medicine. For optimal results, taking all medications at the correct time is essential. Do not stop taking the medication without consulting a healthcare professional unless the diagnosis of ketoacidosis occurs. When the body is experiencing some type of stress, such as trauma, fever, infection, or surgery, the amount of anti-diabetes medicine that a patient may require may change. It is essential to inform your doctor if any of these conditions develop and to follow their advice regarding symptoms.
What is Empagliflozin and what condition does it treat?
Empagliflozin is an SGLT2 inhibitor prescribed to manage type 2 diabetes by helping control blood sugar levels. Marketed as Empamore Tablets 25mg, this glucose-lowering medication works alongside diet and exercise to improve glycemic control in adults. Beyond diabetes management, empagliflozin also reduces the risk of cardiovascular death in patients with type 2 diabetes and established heart disease. It belongs to a class of antidiabetic medicines that target kidney function to promote excess glucose elimination through urine, offering dual metabolic and cardiovascular benefits.
How does Empagliflozin work in the body?
Empagliflozin works by blocking SGLT2 proteins in your kidneys that normally reabsorb glucose back into the bloodstream. By inhibiting this reabsorption process, Empamore Tablets 25mg causes your body to eliminate excess sugar through urine instead. This mechanism lowers blood glucose levels without relying on insulin production, making it distinct from other diabetes medications. The SGLT2 inhibitor action also promotes modest weight loss and blood pressure reduction due to calorie loss and fluid balance changes, providing comprehensive metabolic advantages for type 2 diabetes patients.
How long does Empamore Tablets 25mg take to work?
Empamore Tablets 25mg begins lowering blood sugar within hours of your first dose, with peak glucose-lowering effects occurring around one to two weeks of consistent use. However, optimal blood sugar control and cardiovascular benefits from empagliflozin typically develop over three months of regular treatment. Individual response times vary based on your baseline glucose levels, diet adherence, and overall health status. Most patients notice measurable improvements in their HbA1c readings after two to three months, while weight reduction and blood pressure benefits may become apparent within four to twelve weeks of daily therapy.
When and how should I take Empamore Tablets 25mg?
Take Empamore Tablets 25mg once daily in the morning, with or without food, at the same time each day for best results. Swallow the empagliflozin tablet whole with water without crushing or splitting it. Morning administration is recommended because this diabetes medication increases urination, and taking it early helps minimize nighttime bathroom trips. If you miss a dose, take it as soon as you remember unless it's almost time for your next scheduled dose. Your doctor will prescribe the appropriate strength based on your kidney function and treatment goals.
Is Empamore Tablets 25mg safe for long-term use?
Empamore Tablets 25mg is designed for long-term management of type 2 diabetes and has demonstrated sustained safety in clinical trials lasting several years. The empagliflozin SGLT2 inhibitor maintains its glucose-lowering effectiveness without causing medication tolerance over extended periods. Long-term users benefit from ongoing cardiovascular protection and kidney disease progression reduction. Regular monitoring through routine blood tests and kidney function assessments ensures continued safe use. Most patients tolerate this antidiabetic medication well chronically, though periodic medical reviews help optimize dosing and detect any rare complications early during prolonged treatment.
Can I take Empamore Tablets 25mg with other medicines?
Empamore Tablets 25mg can generally be combined with other diabetes medications including metformin, sulfonylureas, or insulin, often enhancing overall glycemic control. However, empagliflozin may increase hypoglycemia risk when used alongside insulin or insulin-stimulating drugs, potentially requiring dose adjustments of those medications. Diuretics taken with this SGLT2 inhibitor may amplify dehydration risk, while certain blood pressure medicines might need monitoring. Always inform your healthcare provider about all prescription drugs, over-the-counter products, and supplements you're taking to avoid potential interactions and ensure safe, effective diabetes management.
How does Empamore Tablets 25mg compare to similar medicines in its class?
Empamore Tablets 25mg belongs to the SGLT2 inhibitor class alongside dapagliflozin and canagliflozin, all sharing similar glucose-lowering mechanisms. Empagliflozin distinguishes itself with robust cardiovascular mortality reduction data from landmark trials, making it particularly valuable for diabetic patients with heart disease. While all SGLT2 inhibitors promote weight loss and blood pressure reduction, empagliflozin demonstrates consistent efficacy across diverse patient populations. The 25mg strength represents the maximum dose, offering powerful glucose control for patients requiring intensive diabetes management. Side effect profiles remain comparable across this antidiabetic drug class.
Is generic Empagliflozin as effective as branded versions?
Generic empagliflozin contains the identical active ingredient in the same strength as branded versions like Empamore Tablets 25mg, delivering equivalent therapeutic effects for type 2 diabetes management. Regulatory agencies require generic SGLT2 inhibitors to demonstrate bioequivalence, meaning they work identically in your body. The same glucose-lowering potency, cardiovascular benefits, and safety profile apply whether you choose generic or branded formulations. Cost differences reflect marketing and development expenses rather than quality or effectiveness variations. Both options must meet stringent manufacturing standards, making generic empagliflozin a reliable, affordable alternative for long-term diabetes treatment.
Why do patients choose PremiumRxDrugs for Empamore Tablets 25mg?
Patients consistently select PremiumRxDrugs for Empamore Tablets 25mg because of transparent pricing that makes empagliflozin affordable without compromising quality. The pharmacy's manufacturer-direct sourcing guarantees authentic SGLT2 inhibitor medication, eliminating counterfeit concerns common with unverified sellers. Convenient features like easy prescription uploads, simple reordering for chronic diabetes management, and discreet international shipping address practical patient needs. With over ten years serving global communities across the USA, UK, Australia, and Canada, PremiumRxDrugs combines reliability, accessibility, and customer-focused service that makes ongoing type 2 diabetes treatment manageable and stress-free.
What are the common side effects of Empagliflozin?
Common side effects of empagliflozin include urinary tract infections and increased urination frequency due to its glucose elimination mechanism through urine. Some patients experience genital yeast infections, particularly women, because sugar-rich urine creates favorable conditions for fungal growth. Dehydration symptoms like dizziness or lightheadedness may occur, especially in hot weather or when combined with diuretics. Occasional nausea and increased thirst are reported as your body adjusts to this SGLT2 inhibitor. Most side effects remain mild and diminish with continued use, though persistent or bothersome symptoms warrant medical attention to ensure safe diabetes management.
Who should avoid taking Empagliflozin?
Empagliflozin should be avoided by individuals with severe kidney disease or those on dialysis, as impaired kidney function prevents this SGLT2 inhibitor from working effectively. Patients with type 1 diabetes or diabetic ketoacidosis should not use empagliflozin since it's specifically designed for type 2 diabetes management. Those with a history of serious urinary tract infections or recurrent genital infections may need alternative treatments. Pregnant or breastfeeding women should avoid this medication due to limited safety data. Anyone allergic to empagliflozin or experiencing severe dehydration requires careful medical evaluation before starting this antidiabetic therapy.
Login
Sign Up
Login
Sign Up